Clinical Characterization and Outcome of Anti-IgLON5 Disease

Clinical trial NCT06131346 · UNKNOWN

Trial details

NCT number: NCT06131346
Sponsor: Hospices Civils de Lyon
Status: UNKNOWN
Study type: OBSERVATIONAL

Anti-IgLON5 Disease

Start date: 2023-02-23
Primary completion: 2023-05-31
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.